About Training

CDSA works on a national mandate to build capacity and capability in clinical development and translational research in India. We, at CDSA, continually strive to bring in interactive learning opportunities for clinical researchers (investigators), ethics committee members, scientists, biomedical researchers, and all other personnel involved in clinical research/trials. The training programs are conducted as per the recommendations of the Training Advisory Committee (TAC).

CDSA is working with key stakeholders like the Indian drug regulators, Central Drugs Standard Control Organisation (CDSCO), Department of Biotechnology (DBT), Biotechnology Industry Research Assistance Council (BIRAC) – National Biopharma Mission (NBM), Department of Science & Technology (DST), National Institute of Biologicals (NIB), Indian Council of Medical Research (ICMR) in augmenting human capital in the area of clinical development.

The Team

• Dr. Neha Chawla, Head-Training
• Ms. Vandana Chawla, Administrator Training
• Ms. Nidhi Mishra, Program Officer (Technical support for building capacity of clinical trials in India (Phase 1) WHO program)
• Mr. Jitender Ahuja, Training Co-ordinator

Training Advisory Committee

1. Prof. Y. K. Gupta, Ex-Dean (Academics) & Ex-Prof. & Head of Pharmacology, AIIMS, New Delhi (Chairperson)
2. Dr. Temsunaro R. Chandola, Senior Research Scientist, Centre for Health Research and Development, Society for Applied Studies, New Delhi (Centre of Excellence Member) (Vice-Chairperson)
3. Prof. J. P. Muliyil, Former Principal, CMC, Vellore (External Expert)
4. Dr. M. Vishnu Vardhana Rao, Scientist “G” & Director, NIMS, ICMR, New Delhi (ICMR Representative)
5. Prof. Gagandeep Kang, Professor, The Wellcome Trust Research Laboratory, Division of GI Sciences, CMC, Vellore
6. Prof. Shinjini Bhatnagar, Professor of Eminence, THSTI
7. Prof. Usha Menon, Professor – Gynaecological Cancer , UCL London.
8. Dr. Nitya Wadhwa, Faculty In-charge CDSA and Senior Professor, THSTI

Focus areas

There are various training areas but the key focus is on current regulatory and ethical requirements for conducting clinical trials in India, Good Clinical Practice, Good Clinical Laboratory Practice, ethical considerations in clinical research, research methodology, novel vaccine development, and immunization policy in a pandemic, regulatory pathways for medical devices, in-vitro diagnostics, phytopharmaceuticals, biopharmaceuticals, vaccines, etc.

Upcoming Training